---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-24-013505"
form_type: "8-K"
ticker: "TENX"
cik: "0000034956"
company_name: "TENAX THERAPEUTICS, INC."
filed_at: "2024-10-30T23:59:59+00:00"
generated_at: "2026-05-30T08:39:56.680856+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Stockholders approve 7.9M share increase in 2022 Stock Incentive Plan

## Summary
- Approved Amendment No. 2 to 2022 Stock Incentive Plan, increasing authorized shares to 8,336,600 (7,935,912 new shares).
- Vote: 1,176,335 for, 157,003 against, 3,849 abstentions; no broker non-votes.
- Board approved amendment on Sept 6, 2024; stockholders approved on Oct 25, 2024.
- Adjournment proposal also approved: 1,194,879 for, 139,002 against, 3,306 abstentions.

## SEC filing metadata
- accession: 0001654954-24-013505
- form_type: 8-K
- ticker: TENX
- cik: 0000034956
- company_name: TENAX THERAPEUTICS, INC.
- filed_at: 2024-10-30T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/34956/000165495424013505/0001654954-24-013505-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/34956/000165495424013505/tenx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-24-013505
- JSON: https://secwatch.observer/filing/0001654954-24-013505.json
- Plain text: https://secwatch.observer/filing/0001654954-24-013505.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.